1. Fogan R., Zoppi A., Preti P. et al. Sexual activity and plasma testosterone levels in hypertensive males Am J Hypertens 2002 15 137-44
2. Jaffe A., Chen Y., Kisch E.S. et al. Erectile dysfunction m hypertensive subjects Assessment of potential determinants Hypertension 1996 28 859-62
3. English K.M., Steeds R.P. et al. Low dose transdermal testosterone therapy improves angina threshold m men with chronic stable angina Circulation 2000 102 1906-11
4. Channer K.S., Jones T.H. Cardiovascular effects of testosterone implications of the male menopause Heart 2003 89 121-2
5. Jacob S., Rett К., Hemnksen E.J. Antihypertensive therapy and msulm sensi twity do we have to redefine the role ofb blocking agents? Am J Hypertens 1998 11 1258-65
6. Goyal R.K. Hypennsulmemia and msulm resistance m hypertension dif ferential effects of antihypertensive agents Clm Exp Hypertens 1999 21 167-79
7. Sowers J.R. Effects of calcium antagonists on msulm sensitivity and other metabolic parameters Am J Cardiol 1997 79 24-8
8. Suzuki H., Tommaga T., Kumagai H. et al. Effects of first line antihyperten swe agents on sexual function and sex hormones J Hypertens 1988 6 649-51
9. Beer N.A., Jakubowicz D.J., Beer R.M. et al. Effects of nitrendipine on glucose tolerance and serum msulm and dehydroepiandrosterone sulfate levels m insulin-resistant obese and hypertensive men.J Clin Endocrinol Metab 1993; 76:178-83.
10. Caro J.F. Insulin resistance in obese and nonobese men.J Clin Endocrinol Metab 1991; 73: 691-5·
11. Bohlen L., Bienz R,, Diser M. et al. Metabolic-neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.J Cardiovasc Pharmacol 1996; 27: 770-6.
12. Galletti F., Strazzullo P., Capaldo В. et al. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS).J Нуpertens 1999; 17:439-45
13. Draznin B., Sussman K.E., Eckel R.H. et al. Possible role of cytosolic free calcium concentrations in mediating insulin résistons of obesity and byperinsulinemia.J Clin Invest 1988; 82:1848-52.
14. Nestler J.E., McClanahan M.A., Clore J.N., Blackard W.G. Insulin inhibits adrenal 1720-lyase activity in man. J Clin Endocrinol Metab 1992; 74: 362-7.
15. Lin T., Haskell Y., Vinson N., Terracio L. Characterization of insulin and insulin like growth factor I receptor of purified Ley dig cells and their role in steroidogenesis in primary culture: comparative study. Endocrinology 1986; 119: 1641-7.
16. Ворохобина H.B., Сильницкий П.А., Рыбкина Е.В. Функциональное состояние системы гипоталамус-гипофиз-гонады у мужчин с сахарным диабетом и с заболеваниями щитовидной железы. Пробл. эндокринол. 1990; 6:34-8
17. Endre T., Mattiason I. et al. Low testosterone and insulin resistance in hypertension prone men. J Hum Hypertens 1996; 10: 755-76.
18. Neuter J.M., Smith D.H., Graettinger W.F. et al. Metabolic characteristics of hypertension: importance of a positive family history. Am Heart J 1993; 126:924-9.
19. Pandei K.N., Oliver P.M., Maeda N., Smithies O. Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A knockout and gen-duplicated mutant mouse models. Endocrinology 1999; 140: 5112-9.
